Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100042406Phase 4Recruiting
Phase 4, randomised, double-blind trial in None and anxiety disorder comparing Propofol + esketamine arm with Propofol + saline control arm (2 arms). Primary endpoint: Total amount of propofol. Started Jan 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100042406.